Sumitomo Mitsui Trust Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $57.1M | Sell |
908,936
-48,228
| -5% | -$3.36M | 0.04% | 404 |
|
|
2025
Q4 | $63.5M | Sell |
957,164
-15,977
| -2% | -$1.03M | 0.04% | 396 |
|
|
2025
Q3 | $65.5M | Buy |
973,141
+10,307
| +1% | +$816K | 0.04% | 391 |
|
|
2025
Q2 | $84M | Buy |
962,834
+10,234
| +1% | +$802K | 0.05% | 330 |
|
|
2025
Q1 | $65.1M | Buy |
952,600
+6,715
| +0.7% | +$548K | 0.05% | 372 |
|
|
2024
Q4 | $73.6M | Sell |
945,885
-3,680
| -0.4% | -$272K | 0.05% | 352 |
|
|
2024
Q3 | $63.7M | Buy |
949,565
+55,542
| +6% | +$4.56M | 0.04% | 392 |
|
|
2024
Q2 | $101M | Sell |
894,023
-98,981
| -10% | -$12.5M | 0.07% | 253 |
|
|
2024
Q1 | $138M | Sell |
993,004
-17,005
| -2% | -$2.14M | 0.09% | 221 |
|
|
2023
Q4 | $125M | Sell |
1,010,009
-17,661
| -2% | -$1.8M | 0.09% | 226 |
|
|
2023
Q3 | $95.9M | Sell |
1,027,670
-12,198
| -1% | -$1.38M | 0.08% | 274 |
|
|
2023
Q2 | $134M | Sell |
1,039,868
-66,465
| -6% | -$8.04M | 0.1% | 196 |
|
|
2023
Q1 | $129M | Sell |
1,106,333
-26,594
| -2% | -$2.98M | 0.1% | 226 |
|
|
2022
Q4 | $128M | Sell |
1,132,927
-1,444
| -0.1% | -$159K | 0.1% | 230 |
|
|
2022
Q3 | $91.4M | Buy |
1,134,371
+3,492
| +0.3% | +$296K | 0.08% | 312 |
|
|
2022
Q2 | $84.3M | Sell |
1,130,879
-112,265
| -9% | -$10.2M | 0.06% | 339 |
|
|
2022
Q1 | $159M | Sell |
1,243,144
-56,960
| -4% | -$6.23M | 0.11% | 214 |
|
|
2021
Q4 | $175M | Sell |
1,300,104
-430,060
| -25% | -$61.8M | 0.11% | 207 |
|
|
2021
Q3 | $237M | Sell |
1,730,164
-60,088
| -3% | -$7.58M | 0.15% | 146 |
|
|
2021
Q2 | $191M | Sell |
1,790,252
-59,964
| -3% | -$5.76M | 0.11% | 206 |
|
|
2021
Q1 | $166M | Buy |
1,850,216
+88,232
| +5% | +$8.28M | 0.1% | 221 |
|
|
2020
Q4 | $163M | Sell |
1,761,984
-153,428
| -8% | -$13.7M | 0.11% | 212 |
|
|
2020
Q3 | $197M | Buy |
1,915,412
+130,792
| +7% | +$13.7M | 0.13% | 173 |
|
|
2020
Q2 | $181M | Sell |
1,784,620
-445,968
| -20% | -$39.9M | 0.13% | 181 |
|
|
2020
Q1 | $150M | Buy |
2,230,588
+695,176
| +45% | +$43.3M | 0.13% | 172 |
|
|
2019
Q4 | $84M | Buy |
1,535,412
+148,384
| +11% | +$7.04M | 0.07% | 319 |
|
|
2019
Q3 | $51.8M | Sell |
1,387,028
-28,936
| -2% | -$1.12M | 0.05% | 432 |
|
|
2019
Q2 | $53M | Sell |
1,415,964
-197,868
| -12% | -$6.22M | 0.05% | 414 |
|
|
2019
Q1 | $48.1M | Buy |
1,613,832
+77,972
| +5% | +$2.74M | 0.04% | 438 |
|
|
2018
Q4 | $45.4M | Buy |
+1,535,860
| New | +$48.7M | 0.05% | 413 |
|
|
2017
Q4 | – | Sell |
-947,040
| Closed | -$11.6M | – | 904 |
|
|
2017
Q3 | $11.6M | Sell |
947,040
-19,336
| -2% | -$342K | 0.02% | 644 |
|
|
2017
Q2 | $17.7M | Buy |
966,376
+8,068
| +0.8% | +$149K | 0.03% | 597 |
|
|
2017
Q1 | $20.3M | Buy |
958,308
+22,564
| +2% | +$440K | 0.03% | 559 |
|
|
2016
Q4 | $14M | Buy |
+935,744
| New | +$16.6M | 0.02% | 609 |
|
Other funds holding DXCM
VCM
VPM
Sumitomo Mitsui Trust Group's DXCM Position: Q1 2026 in Review
Sumitomo Mitsui Trust Group reduced its DexCom (DXCM) stake by 5% in Q1 2026, selling an estimated $3.36M and leaving 908,936 shares worth $57.1M. The position accounts for 0.04% of the portfolio, ranked #404.
Sumitomo Mitsui Trust Group first reported a position in DXCM in Q4 2016 and has held it in 34 quarters since. The position peaked at $237M in Q3 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Sumitomo Mitsui Trust Group held 908,936 shares of DexCom worth $57.1M as of Q1 2026.
- Sumitomo Mitsui Trust Group sold 48,228 DexCom shares in Q1 2026, an estimated $3.36M.
- DexCom made up 0.04% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #404 holding.
- Sumitomo Mitsui Trust Group first reported a position in DexCom in Q4 2016 and has held it in 34 quarters since.
- Sumitomo Mitsui Trust Group's DexCom position peaked at $237M in Q3 2021.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.